http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP982565-A

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate 1998-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e36600831c02bce02ffff10ace38cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d49180e1575d854f1a54e8d3ae30b671
publicationDate 1999-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP982565-A
titleOfInvention DOSAGE FORMS OF DELAYED RELEASE SERTRALINE
abstract Delayed-release sertraline dosage forms that reduce Tmax and reduce side effects. The forms are generally especially delayed because they are sensitive to their position along the gastrointestinal tract, or temporarily delayed because they are delayed for a predetermined period, independent of their position along the gastrointestinal tract. Live assays are presented to identify such dosage forms.
priorityDate 1998-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617

Total number of triples: 14.